CLLS · Cellectis S.A.
$3.05
-0.13 (-4.09%)
At close · Aug 14
Market Cap
$307.13M
Shares
100.70M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding CLLS
5 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| iShares Biotechnology ETF | — | 339,873 | $1,077,397 | 0.01% | Long | 2026-03-31 | |
| Nomura Healthcare Fund | — | 226,875 | $719,194 | 0.11% | Long | 2026-03-31 | |
| Goldman Sachs Human Evolution ETF | GBIL | 3,272 | $60,368 | 0.12% | Long | 2020-08-31 | |
| ProShares UltraPro Nasdaq Biotechnology | ANEW | 398 | $6,217 | 0.03% | Long | 2020-02-29 | |
| Defiance Nasdaq Junior Biotechnology ETF | ABUF | 475 | $5,990 | 0.08% | Long | 2021-09-30 |
Showing 1–5 of 5 positions
Key facts
CIK
1627281
CUSIP
15117K103
13F (30d)
25 filings
25 filers
Visit website
Investor relations